The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations
Conditions: COVID; Vitamin D Deficiency; Coagulopathy; Disseminated Intravascular Coagulation Interventions: Drug: Aspirin 81 mg; Dietary Supplement: Vitamin D Sponsor: Louisiana State University Health Sciences Center in New Orleans Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials